Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
58.9M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
42.6M
-
Shares change
-
-2.68M
-
Total reported value, excl. options
-
$396M
-
Value change
-
-$31.3M
-
Put/Call ratio
-
0.53
-
Number of buys
-
50
-
Number of sells
-
-59
-
Price
-
$9.31
Significant Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) as of Q4 2015
152 filings reported holding VNDA - Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share as of Q4 2015.
Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.6M shares
of 58.9M outstanding shares and own 72.28% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT CO (6M shares), Palo Alto Investors, LLC (4.03M shares), PAULSON & CO. INC. (3.95M shares), GREAT POINT PARTNERS LLC (2.1M shares), Stonepine Capital Management, LLC (1.92M shares), STATE STREET CORP (1.69M shares), ARMISTICE CAPITAL, LLC (1.63M shares), BlackRock Fund Advisors (1.62M shares), MILLENNIUM MANAGEMENT LLC (1.54M shares), and VANGUARD GROUP INC (1.48M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.